All Chemistry World articles in Archive 2010-2015 – Page 142
-
FeatureA forensic injustice?
Jon Evans examines how the closure of the Forensic Science Service has affected justice and science in the UK
-
Business
Ups and downs for erectile dysfunction drugs
First new drug in a decade approved in Europe as Viagra patent expires
-
OpinionThe Choshu five
Alwyn Davies recounts how five Japanese students and their chemist mentor changed Japanese society forever
-
Research
Self-contained chemical synthesis
Reactionware made on 3D printer manipulates reactions with gravity
-
Research
Molecular transistor for cheaper, greener electronics
Reduced graphene oxide electrode enables photoswitchable layer to be employed
-
Research
Sustainable iron catalyst for clean hydrogenation
Precious metal catalysts replaced with polymer-supported iron
-
OpinionFlashback: 1988 – chemical weapon collaboration
Russian and British teams discuss chemical warfare as a step towards a ban
-
PodcastResveratrol
Can a compound in red wine protect against heart attack and cancer? Phillip Broadwith investigates resveratrol
-
NewsScience survives latest UK spending round
Plan for spending in 2015-16 boosts capital funding for science but continues freeze of research budget
-
-
NewsUN report warns of global rise in legal highs
World Drug Report suggests designer drugs are becoming more common
-
-
-
Research
Date rape drug sensor
Fluorescent dye library screened to find compound suitable for detecting gamma-butyrolactone in alcoholic drinks
-
Research
Glucose-sensing contact lens could run on power of tears
Fuel cell uses chemicals in tears to create power without altering glucose levels
-
-
FeaturePress P to print
The use of 3D printers to create lab equipment, deliver reagents and even build biomaterials is on the rise. Katharine Sanderson installs drivers and prints away
-
Research
A foaming protein from the horse’s mouth
Structure of latherin solved, suggesting a novel mode of action for the foaming protein
-
Business
NHS to offer breast cancer prevention drugs
Five-year course of tamoxifen or raloxifene recommended for high risk women